Global Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Forecast 2024-2030- Product Image

Sale

Global Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Forecast 2024-2030

Report
198 Pages
March 2024
Region: Global
360iResearch™
ID: 5460320

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Spine Biologics Market size was estimated at USD 3.00 billion in 2023, USD 3.15 billion in 2024, and is expected to grow at a CAGR of 5.24% to reach USD 4.30 billion by 2030.

Spine biologics refer to a category of medical products and treatments that utilize biological material to promote healing, regeneration, and stabilization of spinal tissues. Spine biologics are medical products and treatments utilizing biological material to promote spinal tissue healing, regeneration, and stabilization. The market for spine biologics is witnessing significant growth and is poised for further expansion in the coming years. Patients and healthcare providers are increasingly looking forward to less invasive approaches that offer shorter recovery times, reduced postoperative pain, and improved patient outcomes. The incidence of degenerative spine disorders is rising due to an aging population and sedentary lifestyles, increasing the number of patients seeking treatment for these conditions and driving the market's growth. However, the high cost of treatment remains a significant challenge in the spine biologics market. The expenses associated with synthetic bone graft substitutes, growth factors, and other biologics contribute to the overall treatment costs. Nevertheless, ongoing advancements in biomaterials are revolutionizing the treatment of spine disorders, where innovations in biocompatible materials, such as synthetic bone grafts and tissue-engineered scaffolds, enhance the efficacy and durability of spine biologics. Furthermore, governments recognize the potential of spine biologics in improving patient care and fund research and development initiatives. This support facilitates scientific advancements, clinical trials, and the development of new products in the spine biologics market.

Regional Insights

The market is witnessing a robust expansion in the Americas primarily due to the growing adoption of advanced medical technologies and the increasing prevalence of degenerative spine disorders. The region has a well-developed healthcare infrastructure, and favorable reimbursement regulations encourage the implementation of spine biologics treatments. Additionally, rising healthcare expenditure, technological advancements, and the presence of key market players further drive market growth in the Americas. The EMEA region is also witnessing substantial growth in the spine biologics market. Countries in Europe, such as France, Germany, and the United Kingdom, are at the forefront of adopting innovative spine biologics therapies. The region benefits from a high prevalence of spinal disorders, a well-developed healthcare system, and increasing investments in research and development. Moreover, the availability of government funding and supportive regulatory frameworks further contribute to the market's expansion in the EMEA region. The spine biologics market is rapidly growing in the APAC region due to several factors such as increasing geriatric population, rising disposable incomes, and improving healthcare infrastructure. Countries such as China, Japan, and India are witnessing a surge in the prevalence of spinal disorders, creating a substantial market opportunity. Additionally, government initiatives promoting medical R&D and a large patient pool contribute to the market's growth in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Spine Biologics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Spine Biologics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Spine Biologics Market, highlighting leading vendors and their innovative profiles. These include Alphatec Spine, Inc., Arthrex Inc., Aziyo Biologics, Baxter International Inc., Biomatlante SAS, Bone Biologics Corp., Camber Spine Technologies, LLC, Cerapedics, Inc, ChoiceSpine LLC, CoreLink, LLC by ZAVATION, Globus Medical, Inc., Induce Biologics USA Inc., Innovasis, Inc., Integra LifeSciences Corporation, InVivo Therapeutics Corp., Johnson & Johnson Services, Inc., Kuros Biosciences A.G., Life Spine, Inc., LifeNet Health, Medtronic PLC, MTF Biologics, ORHub Inc, Orthofix Medical Inc., RTI Surgical, Inc., Smith & Nephew PLC, Spinal Elements, Inc., Stryker Corporation, Tyber Medical LLC, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc.

Market Segmentation & Coverage

This research report categorizes the Spine Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Bone Graft Substitutes
  - Bone Morphogenetic Proteins
  - Synthetic Bone Grafts
- Cell-Base Matrix
- Spinal Allografts
  - Demineralized Bone Matrix
  - Machined Bones Allograft
Application
- Non-Fusion
- Spinal Fusion
End-user
- Ambulatory Surgical Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Spine Biologics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Spine Biologics Market?
What are the technology trends and regulatory frameworks in the Spine Biologics Market?
What is the market share of the leading vendors in the Spine Biologics Market?
Which modes and strategic moves are suitable for entering the Spine Biologics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Spine Biologics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand and preference for minimally invasive procedures
5.1.1.2. Rising incidence of degenerative spine disorders and rise in treatment rates
5.1.1.3. Proliferation in advancements of bone grafting procedures
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in biomaterials improving the treatment of spine disorders
5.1.3.2. Government funding to expand spine biologics research
5.1.4. Challenges
5.1.4.1. Issues related to product recalls
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Spine Biologics Market, by Product

6.1. Introduction
6.2. Bone Graft Substitutes
6.3.1. Bone Morphogenetic Proteins
6.3.2. Synthetic Bone Grafts
6.3. Cell-Base Matrix
6.4. Spinal Allografts
6.5.1. Demineralized Bone Matrix
6.5.2. Machined Bones Allograft

7. Spine Biologics Market, by Application

7.1. Introduction
7.2. Non-Fusion
7.3. Spinal Fusion

8. Spine Biologics Market, by End-user

8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Hospitals

9. Americas Spine Biologics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Spine Biologics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Spine Biologics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. New Product Launch & Enhancement
12.3.1.1. PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
12.3.1.2. Induce Biologics Announces Launch of NMP Cancellous Strips
12.3.2. Award, Recognition, & Expansion
12.3.2.1. Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Alphatec Spine, Inc.
13.1.2. Arthrex Inc.
13.1.3. Aziyo Biologics
13.1.4. Baxter International Inc.
13.1.5. Biomatlante SAS
13.1.6. Bone Biologics Corp.
13.1.7. Camber Spine Technologies, LLC
13.1.8. Cerapedics, Inc
13.1.9. ChoiceSpine LLC
13.1.10. CoreLink, LLC by ZAVATION
13.1.11. Globus Medical, Inc.
13.1.12. Induce Biologics USA Inc.
13.1.13. Innovasis, Inc.
13.1.14. Integra LifeSciences Corporation
13.1.15. InVivo Therapeutics Corp.
13.1.16. Johnson & Johnson Services, Inc.
13.1.17. Kuros Biosciences A.G.
13.1.18. Life Spine, Inc.
13.1.19. LifeNet Health
13.1.20. Medtronic PLC
13.1.21. MTF Biologics
13.1.22. ORHub Inc
13.1.23. Orthofix Medical Inc.
13.1.24. RTI Surgical, Inc.
13.1.25. Smith & Nephew PLC
13.1.26. Spinal Elements, Inc.
13.1.27. Stryker Corporation
13.1.28. Tyber Medical LLC
13.1.29. Xtant Medical Holdings, Inc.
13.1.30. Zimmer Biomet Holdings, Inc.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. SPINE BIOLOGICS MARKET RESEARCH PROCESS
FIGURE 2. SPINE BIOLOGICS MARKET SIZE, 2023 VS 2030
FIGURE 3. SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SPINE BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. SPINE BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SPINE BIOLOGICS MARKET DYNAMICS
FIGURE 7. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. SPINE BIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 8. SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 13. SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 39. CANADA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 40. CANADA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CANADA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 44. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. MEXICO SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. CHINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. CHINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 66. CHINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 67. CHINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. CHINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. INDIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. INDIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 71. INDIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 72. INDIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. INDIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 76. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 77. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. JAPAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 80. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 81. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 82. JAPAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. JAPAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 87. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 105. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. THAILAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 111. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 112. THAILAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. THAILAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 116. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. DENMARK SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 126. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 127. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 128. DENMARK SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. DENMARK SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EGYPT SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 132. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 133. EGYPT SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. EGYPT SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. FINLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 137. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 138. FINLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. FINLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 141. FRANCE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 142. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. FRANCE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. GERMANY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. GERMANY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. GERMANY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 148. GERMANY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. GERMANY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. ITALY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. ITALY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 157. ITALY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 158. ITALY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. ITALY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 161. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 162. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 163. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NORWAY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 171. NORWAY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 172. NORWAY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 173. NORWAY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NORWAY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. POLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 176. POLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. POLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 178. POLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. POLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. QATAR SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. QATAR SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 182. QATAR SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 183. QATAR SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. QATAR SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SPAIN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. SPAIN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 202. SPAIN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 203. SPAIN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 204. SPAIN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 212. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 213. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. TURKEY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. TURKEY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 217. TURKEY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 218. TURKEY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. TURKEY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 231. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 232. SPINE BIOLOGICS MARKET LICENSE & PRICING

Companies Mentioned

Alphatec Spine, Inc.
Arthrex Inc.
Aziyo Biologics
Baxter International Inc.
Biomatlante SAS
Bone Biologics Corp.
Camber Spine Technologies, LLC
Cerapedics, Inc
ChoiceSpine LLC
CoreLink, LLC by ZAVATION
Globus Medical, Inc.
Induce Biologics USA Inc.
Innovasis, Inc.
Integra LifeSciences Corporation
InVivo Therapeutics Corp.
Johnson & Johnson Services, Inc.
Kuros Biosciences A.G.
Life Spine, Inc.
LifeNet Health
Medtronic PLC
MTF Biologics
ORHub Inc
Orthofix Medical Inc.
RTI Surgical, Inc.
Smith & Nephew PLC
Spinal Elements, Inc.
Stryker Corporation
Tyber Medical LLC
Xtant Medical Holdings, Inc.
Zimmer Biomet Holdings, Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.15 Billion
Forecasted Market Value ( USD ) by 2030	$ 4.3 Billion
Compound Annual Growth Rate	5.2%
Regions Covered	Global
No. of Companies Mentioned	30

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Spine Biologics Market Size, Share & Trends Analysis Report By Product (Spinal Allografts, Bone Graft Substitutes, Cell-based Matrix), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2024 - 2030

Spine Biologics - Global Strategic Business Report

Spine Biologics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2023 to 2031

Global Spine Biologics Market Report by Product, Surgery Type, End User, and Region 2023-2028

Spine Biologic Market Report: Trends, Forecast and Competitive Analysis to 2030

About the Spine Biologics Market